Skip to main content

Point72 (DIFC) Ltd

SEC CIK
0002017863
Latest filing
Nov 14, 2025

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Point72 (DIFC) Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overviewAll 13F holders of SYREFull Q3 2025 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2024
Holdings of SYRE by Point72 (DIFC) Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−22−100.0%Sold outHolders
Q1 202422$847<0.1%–No prior filingHolders